MARKET

RHHBY

RHHBY

Roche Hldg
OTCQX
52.65
+0.27
+0.52%
Opening 13:00 05/29 EDT
OPEN
52.84
PREV CLOSE
52.38
HIGH
52.96
LOW
52.49
VOLUME
34.38K
TURNOVER
1.81M
52 WEEK HIGH
59.03
52 WEEK LOW
36.39
MARKET CAP
--
P/E (TTM)
20.84
1D
5D
1M
3M
1Y
5Y
1D
Chugai Pharmaceutical publishes 2025 annual report
PUBT · 15h ago
Foundation Medicine integrates Roche navify Clinical Hub to expand digital oncology decision-support tools
PUBT · 1d ago
Wall Street Underestimates Novo Nordisk's GLP-1 Comeback
Seeking Alpha · 1d ago
South Korea: Asia's Second Innovation Engine
Seeking Alpha · 2d ago
Immunic names ex-Genentech executive Erik Lundgren CEO, replacing Daniel Vitt
PUBT · 2d ago
EXCLUSIVE: Immunic Appoints Former Genentech Exec Erik Lundgren As CEO
Benzinga · 2d ago
Deutsche Bank Sticks to Their Hold Rating for Roche Holding AG (RHHVF)
TipRanks · 2d ago
Roche's New Liver Disease Panel Brings Certified Digital Algorithms To Transform Chronic Liver Disease Management Worldwide
Benzinga · 2d ago
More
About RHHBY
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Webull offers Roche Holding AG (ADR) stock information, including OTCQX: RHHBY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RHHBY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RHHBY stock methods without spending real money on the virtual paper trading platform.